Home526139 • BOM
add
Transgene Biotek Ltd
Previous close
₹4.52
Day range
₹4.65 - ₹4.74
Year range
₹3.91 - ₹12.46
Market cap
358.39M INR
Avg Volume
92.37K
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Market news
.INX
1.83%
Financials
Income Statement
Revenue
Net income
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 1.02M | 127.33% |
Operating expense | 1.58M | -16.19% |
Net income | -734.00K | 44.64% |
Net profit margin | -71.75 | 75.65% |
Earnings per share | — | — |
EBITDA | -328.50K | -103.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 113.00K | 7.54% |
Total assets | 1.42B | -0.21% |
Total liabilities | 1.31B | -0.03% |
Total equity | 108.32M | — |
Shares outstanding | 75.77M | — |
Price to book | 3.16 | — |
Return on assets | — | — |
Return on capital | -0.57% | — |
Cash Flow
Net change in cash
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -734.00K | 44.64% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1990
Website